... or by any means—electronic, mechanical, photocopying, recording, or otherwise—without the permission of the Kellogg School of Management. New Products Pioneering Strategy Pricing Peter Sheffield settled back in his chair with a large stack of reports on Lilly's newest drug, Xigris, a treatment...

..., recording, or otherwise—without the permission of the Kellogg School of Management. New Products Pioneering Strategy Pricing Securing approval from the U.S. Food and Drug Administration (FDA) to market Xigris was far more challenging than Lilly had anticipated. Following standard procedures...